Tag: feasibility and GCP overlap

Regulatory Considerations During Feasibility Assessments in Clinical Trials Understanding Regulatory Considerations During Feasibility Assessments Feasibility assessments are a critical step in clinical trial start-up, allowing sponsors and CROs to evaluate whether potential sites can successfully execute a protocol. However, beyond site infrastructure, patient pools, and investigator experience, regulatory compliance is equally vital. Inadequate attention to…

Read More “Regulatory Considerations During Feasibility Assessments in Clinical Trials” »

Understanding Regulatory Considerations During Feasibility Assessments Feasibility assessments are a critical step in clinical trial start-up, allowing sponsors and CROs to evaluate whether potential sites can successfully execute a protocol. However, beyond site infrastructure, patient pools, and investigator experience, regulatory compliance is equally vital. Inadequate attention to regulatory requirements during feasibility can lead to delays,…

Read More “Regulatory Considerations During Feasibility Assessments in Clinical Trials” »